DMSO Products for Stem Cell and Immunotherapy Cryopreservation

NHS Blood and Transplant (NHSBT) is conducting a market engagement exercise to identify suppliers and manufacturers of Dimethyl Sulphoxide (DMSO) for cryopreservation of stem cell and immunotherapy products. NHSBT seeks to understand the current market, available products, supply chain capabilities, and quality standards before launching a formal procurement. The required product must be sterile and pyrogen-free with minimum 99.9% purity, available in multiple formats including vials, bottles, bags, and syringes for use in NHSBT's Cellular and Molecular Therapies laboratories. Suppliers should be prepared to discuss quality assurance processes, business continuity plans, supply chain resilience, sustainability practices, and plans for future product innovations. This is a preliminary engagement opportunity for manufacturers interested in supplying critical cryopreservation materials to a major UK healthcare organization.